Albumin-fused long-acting FGF21 analogue for the treatment of non-alcoholic fatty liver disease
Mayuko Chikamatsu, Hiroshi Watanabe, Yuhi Shintani, Ryota Murata, Masako Miyahisa, Ayano Nishinoiri, Tadashi Imafuku, Mei Takano, Nanaka Arimura, Koh‐ichi Yamada, Miya Kamimura, Baki Mukai, Takao Satoh, Hitoshi Maeda, Toru Maruyama
Topics & Concepts
Internal medicineEndocrinologyFGF21Fatty liverAdipose tissueSteatosisCD36AdiponectinMedicineInsulin resistanceInsulinReceptorFibroblast growth factorDiseaseFibroblast Growth Factor ResearchKruppel-like factors researchLipid metabolism and biosynthesis